Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastomaAlexander Scholz(University Hospital Frankfurt), Yvonne Reiss(Goethe University Frankfurt)EMBO Molecular MedicineDecember 14, 201510.15252/emmm.201505505Cited by 170SaveCiteExport RISWatch citationsRelated PapersAngiopoietin-2 promotes myeloid cell infiltration in a β2-integrin–dependent manner|Blood|2011|100